DualityBio’s HER2 ADC Trastuzumab Pamirtecan Accepted for NMPA Review in China

DualityBio announced that the Biologics License Application (BLA) for the investigational antibody-drug conjugate ("ADC") trastuzumab pamirtecan ("T-Pam"...

April 13, 2026 | Monday | News
Gan & Lee Pharmaceuticals Partners with JW Pharmaceutical to Advance Bi-Weekly GLP-1 Therapy in South Korea

Gan & Lee Pharmaceuticals (hereinafter referred to as "Gan & Lee", SSE: 603087) announced the signing of an exclusive licensing agreement with JW...

April 13, 2026 | Monday | News
Innovaccer, Infinia Forge Alliance to Accelerate UAE’s Digital Health Transformation

Innovaccer Inc., a leading healthcare AI company, and Infinia Technologies, a next-generation digital transformation company and a subsidiary of Sirius I...

April 10, 2026 | Friday | News
Nxera Pharma Achieves Second Milestone in Lilly Diabetes Collaboration

Nxera Pharma Co., Ltd. announces that it has achieved a second development milestone under its multi-target collaboration and license agreement with Eli ...

April 10, 2026 | Friday | News
Novartis Scales Global Community Health Efforts to Tackle Gaps in Chronic Disease Care

Strengthens three community health models spanning community‑embedded care, earlier intervention and data‑driven population health Scales program ...

April 10, 2026 | Friday | News
Emergent BioSolutions Expands Access to NARCAN Nasal Spray with New Carrying Case, Multipacks, and Campus Outreach Initiative

  Emergent BioSolutions Inc. announced a series of initiatives designed to help increase access to NARCAN® Nasal Spray and encourage the pub...

April 09, 2026 | Thursday | News
BioOra Limited and Octane Biotech Inc. Sign LOI to Expand CAR-T Manufacturing with Cocoon® Platform

BioOra Limited ("BioOra"), a commercial-stage cell therapy company advancing CAR-T therapies for cancer patients, and Octane Biotech Inc., an Octane Medi...

April 09, 2026 | Thursday | News
NexTel Medical Corp Initiates First Phase of Global Rollout for Exosome-Based Cancer Screening Test

NexTel Medical Corp f/k/a Exousia Pro, Inc. (OTCPK: MAJI), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery syste...

April 09, 2026 | Thursday | News
Mesoblast Limited Secures U.S. Food and Drug Administration IND Clearance for Registrational Trial of Ryoncil in Duchenne Muscular Dystrophy

Partnering with Parent Project Muscular Dystrophy to ensure timely access to the trial for eligible patients ~15,000 children are living with DMD in the...

April 09, 2026 | Thursday | News
Tenvie Therapeutics Doses First Patient in Phase 1 Trial of CNS-Penetrant NLRP3 Inhibitor TNV262

First candidate from Tenvie’s product engine to enter clinical development Phase 1 first-in-human study to evaluate single and multiple ascendin...

April 08, 2026 | Wednesday | News
Akari Therapeutics Partners with WuXi XDC to Advance First-in-Class RNA Splicing ADC Payload

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulating p...

April 08, 2026 | Wednesday | News
SonoNeu Emerges from Stealth to Advance Sonogenetics as a Breakthrough Drug-Free Therapeutic Modality

Sonogenetics, discovered by SonoNeu founder Sreekanth Chalasani, is a new modality using ultrasound to precisely control specific cells ‘tagged&r...

April 08, 2026 | Wednesday | News
FDA Extends EYLEA HD Dosing Interval to 20 Weeks, Advancing Long-Term Retinal Care

Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements with exte...

April 07, 2026 | Tuesday | News
OneCyte and Kemp Proteins Partner to Transform Cell Line Development

OneCyte, a leader in high-throughput single-cell analysis and cell line development technologies, and Kemp Proteins, a pioneer in protein engineering and...

April 06, 2026 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close